Progress in Prevention and Treatment of Acute Kidney Injury Moving Beyond Kidney Attack

Grants

Funding Acknowledgements

All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Kellum reports receipt of grants and personal fees from Astute Medical and Baxter, and personal fees from NixStage outside the submitted work; and a pending patent (University of Pittsburgh and Astute Medical) on the use of cell-cycle arrest biomarkers to guide application of remote ischemic preconditioning. Dr Bellomo reports receipt of a grant, personal fees, and nonfinancial support from Baxter; personal fees and nonfinancial support from B Braun Medical; and personal fees from Edwards Lifesciences. Dr Ronco reports receipt of personal fees from GE, Fresenius, Estor, Toray, Biomerieux, B Braun Medical, Medtronic, Astute, Baxter, Jaffron, and Aferetica outside the submitted work.